Sideroblastic anemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{Sideroblastic anemia}} | {{Sideroblastic anemia}} | ||
{{CMG}} | {{CMG}} | ||
Line 15: | Line 16: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:needs overview]] | [[Category:needs overview]] | ||
[[Category:needs content]] |
Revision as of 17:03, 4 February 2013
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Sideroblastic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sideroblastic anemia medical therapy On the Web |
American Roentgen Ray Society Images of Sideroblastic anemia medical therapy |
Risk calculators and risk factors for Sideroblastic anemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
The anemia can be so severe that support with transfusion is required. These patients usually do not respond to erythropoietin therapy. Some cases have been reported that the anemia is reversed or heme level is improved through use of moderate to high doses of pyrodoxine. (vitamin B6)